HUP1900358A1 - Lamotrigin és szertralin hatóanyag tartalmú gyógyszerkészítmények, ezek elõállítása és alkalmazása - Google Patents
Lamotrigin és szertralin hatóanyag tartalmú gyógyszerkészítmények, ezek elõállítása és alkalmazásaInfo
- Publication number
- HUP1900358A1 HUP1900358A1 HU1900358A HUP1900358A HUP1900358A1 HU P1900358 A1 HUP1900358 A1 HU P1900358A1 HU 1900358 A HU1900358 A HU 1900358A HU P1900358 A HUP1900358 A HU P1900358A HU P1900358 A1 HUP1900358 A1 HU P1900358A1
- Authority
- HU
- Hungary
- Prior art keywords
- sertraline
- pharmaceutical composition
- composition containing
- containing lamotrigine
- lamotrigine
- Prior art date
Links
- PYZRQGJRPPTADH-UHFFFAOYSA-N lamotrigine Chemical compound NC1=NC(N)=NN=C1C1=CC=CC(Cl)=C1Cl PYZRQGJRPPTADH-UHFFFAOYSA-N 0.000 title 1
- 229960001848 lamotrigine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title 1
- 229960002073 sertraline Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1900358A HUP1900358A1 (hu) | 2019-10-12 | 2019-10-12 | Lamotrigin és szertralin hatóanyag tartalmú gyógyszerkészítmények, ezek elõállítása és alkalmazása |
EP20201399.1A EP3804697A1 (en) | 2019-10-12 | 2020-10-12 | Combination pharmaceutical preparation for oral application comprising lamotrigine and sertraline, its preparation and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1900358A HUP1900358A1 (hu) | 2019-10-12 | 2019-10-12 | Lamotrigin és szertralin hatóanyag tartalmú gyógyszerkészítmények, ezek elõállítása és alkalmazása |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP1900358A1 true HUP1900358A1 (hu) | 2021-04-28 |
Family
ID=89992996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU1900358A HUP1900358A1 (hu) | 2019-10-12 | 2019-10-12 | Lamotrigin és szertralin hatóanyag tartalmú gyógyszerkészítmények, ezek elõállítása és alkalmazása |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3804697A1 (hu) |
HU (1) | HUP1900358A1 (hu) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230403B1 (hu) | 2003-12-19 | 2016-04-28 | Pál Kocsis | Nátrium csatorna blokkoló és szerotonin újrafelvétel gátló tartalmú gyógyszerkészítmény |
WO2006103506A1 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Sertraline-containing pharmaceutical compositions and a process for preparation thereof |
US20100016322A1 (en) * | 2007-02-28 | 2010-01-21 | Nagesh Nagaraju | Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same |
EP2175728B1 (en) | 2007-07-13 | 2014-09-10 | Icagen, Inc. | Sodium channel inhibitors |
GB201003731D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
PL2983787T3 (pl) | 2013-04-12 | 2020-04-30 | Icahn School Of Medicine At Mount Sinai | Sposób leczenia zespołu stresu pourazowego |
CA2915536C (en) | 2013-06-19 | 2021-10-19 | F. Hoffmann-La Roche Ag | Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives |
-
2019
- 2019-10-12 HU HU1900358A patent/HUP1900358A1/hu unknown
-
2020
- 2020-10-12 EP EP20201399.1A patent/EP3804697A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP3804697A1 (en) | 2021-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL284835A (en) | Pharmaceutical combination containing TNO155 and ribociclib | |
EP3706741A4 (en) | PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
IL287905A (en) | A pharmaceutical preparation containing brexanolone, gnaxolone or zoranolone and its use | |
ZA202105752B (en) | Haloallylamine compounds and application thereof | |
GB201911517D0 (en) | Pharmaceutical composition | |
IL311331A (en) | Pharmaceutical preparation and its use | |
EP3954689C0 (en) | COMPOUND DERIVATIVES OF PYRAZOLOPYRAZINE, PHARMACEUTICAL COMPOSITION AND ASSOCIATED USE | |
EP3697411A4 (en) | NEW PHARMACEUTICAL COMPOSITION AND ITS USE | |
IL285866A (en) | A pharmaceutical preparation containing acetaminophen and ibuprofen | |
IL279877A (en) | Ibusidanib forms and pharmaceutical preparations | |
IL276783A (en) | The composition and pharmaceutical compound containing it | |
EP3753554A4 (en) | SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING LACOSAMIDE | |
ZA202104261B (en) | Combination pharmaceutical compositions and methods thereof | |
HUP1900358A1 (hu) | Lamotrigin és szertralin hatóanyag tartalmú gyógyszerkészítmények, ezek elõállítása és alkalmazása | |
IL285916A (en) | New preparations and their use | |
ZA202106721B (en) | Pharmaceutical composition containing antibody against il-5 and use thereof | |
SG11202110315SA (en) | Pharmaceutical composition | |
HUE064916T2 (hu) | Gyógyászati készítmény | |
SG11202010069SA (en) | Dipeptide and pharmaceutical composition containing same | |
IL292646A (en) | Pharmaceutical combination and its use | |
IL285728A (en) | Pharmaceutical composition | |
GB201912686D0 (en) | Pharmaceutical composition | |
GB201907591D0 (en) | Composition and use | |
GB201908003D0 (en) | Pharmaceutical composition | |
GB201907351D0 (en) | Compositions and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |